Corneal allogenic intrastromal ring segments improve visual and topographic outcomes in advanced keratoconus : Short Title: CAIRS in Advanced Keratoconus

角膜同种异体基质内环段改善晚期圆锥角膜患者的视力和地形图结果:简称:晚期圆锥角膜的角膜同种异体基质内环段植入术

阅读:2

Abstract

This study aims to evaluate the efficacy and safety of corneal allogeneic intrastromal ring segments (CAIRS) in patients with advanced keratoconus. This retrospective observational study included 25 eyes of 20 patients with advanced keratoconus (defined as a maximum keratometry (Kmax) of ≥ 58.0 D) who had unsatisfactory vision with spectacles and intolerance to scleral lenses. All patients underwent femtosecond laser-assisted tunnel creation, followed by implantation of allogeneic stromal segments prepared from donor corneal tissue. In cases of suboptimal outcomes, tissue reshaping or double segment implantation was performed. Pre- and postoperative evaluations included uncorrected (UDVA) and corrected distance visual acuity (CDVA), manifest refraction, spherical equivalent (SE), Scheimpflug-based tomography, keratometric parameters, corneal thickness, and higher-order aberrations. Patients were followed for a mean of 11 months. Mean UDVA improved significantly from 1.42 ± 0.33 LogMAR to 0.46 ± 0.27 LogMAR (p < 0.001), and CDVA improved from 1.18 ± 0.44 LogMAR to 0.25 ± 0.16 LogMAR (p < 0.001), with nearly half of the patients gaining 10 Snellen lines. Mean SE decreased from - 9.66 D to - 1.33 D (p < 0.001). Significant reductions in K1, K2, Kmean, and Kmax were observed (all p < 0.05), with coma aberration improving from 1.39 μm to 0.41 μm (p = 0.005). Central corneal thickness remained stable. No adverse events occurred. In conclusion, CAIRS provided substantial visual, refractive, and topographic improvements in advanced keratoconus, including very severe cases. Larger, prospective, long-term studies are warranted to confirm its role in advanced keratoconus management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。